Endocrine xenoestrogenics disrupters: Molecular mechanisms and detection methods;Les perturbateurs endocriniens xénoœstrogéniques: Mécanismes moléculaires et méthodes de détection

Therapie

Volumn 62, Issue 5, 2007, Pages 369-386

  Mnif, Wissem ^a,b   Pillon, Arnaud ^b   Balaguer, Patrick ^b   Bartegi, Aghleb ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b INSERM   (France)

Author keywords

Endocrine disrupters; Estrogens receptors; Methods of detection; Potential risk; Xenoestrogens

Indexed keywords

ENDOCRINE DISRUPTOR; ESTROGEN DERIVATIVE;

BEHAVIOR; BONE GROWTH; BONE REMODELING; CARDIOVASCULAR FUNCTION; ENDOCRINE SYSTEM; ENVIRONMENTAL EXPOSURE; HORMONE RELEASE; HUMAN; INTESTINE FUNCTION; KIDNEY FUNCTION; MARINE ENVIRONMENT; METABOLIC REGULATION; NONHUMAN; NUTRITION; POLLUTANT; PRIORITY JOURNAL; REPRODUCTION; REVIEW; RISK ASSESSMENT; STRESS; WILDLIFE;

EID: 39749147266     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2007062     Document Type: Article

References (140)

1. Kavlock RJ, Daston GP, DeRosa C, et al. Research needs for the risk assessment of health and environmental effects of endocrine disrupters: A report of the U.S. EPA-sponsored workshop. Environ. Health Persp1996; 104: 714-40
2. Mnif W, Pillon A, Banni M, et al. Etude in vitro de l'activité œstrogénique des eaux usées en entrée des stations d'épuration. Microbiologie et hygiène Alimentaire 2004; 16: 12-7
3. Mnif W, Barbouche R, Pillon A, et al. Detection of the estrogenic and androgenic activities of Wastewater treatment plants using cultured cell lines. Microbiologie et hygiène Alimentaire 2006; 18: 65-9
4. Mnif W, Pillon A, Duchesne MJ, et al. Water and sediment waste rejected in Hamdoun's river are major endocrine disrupting system. Revista de Toxicologia 2006; 23: 118-24
5. Soto AM, Michaelson CL, Prechtl N, et al. Assays to measure estrogen and androgen agonists and antagonists. Adv Exp Med. Biol 1999; 444: 9-23
6. Lemaire G, Balaguer P, Michel S, et al. Activation of retinoic acid receptor-dependent transcription by organochlorine pesticides. Toxicology and Applied Pharmacology 2005; 202: 38-49
7. Fenet H, Gomez E, Pillon A, et al. Estrogenic Activity in Water and Sediments of a French River ; contribution of alkylphenols. Arch Environ Contam Toxicol 2003; 44: 1-6
8. Pillon A, Boussioux AM, Escande A, et al. Binding of Estrogenic Compounds to Recombinant Estrogen Receptor alpha: Application to Environmental Analysis. Environ Health Perspect 2005; 113: 278-84
9. Lemaire G, Mnif W, Mauvais P, et al. Activation of α- and β-estrogen receptors by persistent pesticides in reporter cell lines. Life Sciences 2006; 79: 1160-9
10. Cos P, De Bruyne T, Apers S, et al. Phytœstrogens: recent developments. Planta Med 2003; 69: 589-99
11. Kuiper GG, Lemmen JG, Carisson B, et al. Interaction of estrogenic chemicals and phytœstrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-63
12. Thayer KA, Ruhlen RL, Howdeshell KL, et al. Altered prostate growth and daily sperm production in male mice exposed prenatally to subclinical doses of 17alpha-ethinyl oestradiol. Hum Reprod 2001; 16: 988-96
13. Kim HS, Shin JH, Moon HJ, et al. Evaluation of the 20-day pubertal female assay in Sprague-Dawley rats treated with DES, tamoxifen, testosterone, and flutamide. Toxicol Sci 2002; 67: 52-62
14. Soto AM, Justicia H, Wray JW, et al. p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 1991; 92: 167-73
15. Vom Saal FS, Cooke PS, Buchanan DL, et al. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind. Health 1998; 14: 239-60
16. Kelce WR, Stone CR, Laws SC, et al. Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 1995; 375: 581-5
17. Cavaillès C. Estrogènes, récepteurs nucléaires et cofacteurs transcriptionnels. Ref Gynecol Obstet 2001; 8: 323-9
18. Gronemeyer H, Laudet V. Transcription factors 3: Nuclear receptors. Protein Profile 1995; 2: 1173-308
19. Bourguet W, Germain P, Gronemeyer H. Nuclear receptor ligand-binding domains: 3D structures, molecular interactions and pharmacological implications. Trends in Pharmacological Sciences 2000; 21: 381-8
20. Tenbaum S, Baniahmad A. Nuclear receptors: structure, function and involvement in disease. Int J Biochem Cell Biol 1997; 29: 1325-41
21. Kumar V, Green S, Staub A, et al. Localisation of the oestradiol- Binding and putative DNA- binding domains of the human œstrogen receptor. EMBO 1986; 15: 2231-6
22. Nilson S, Makela S, Trenter E, et al. Mecanisms of Estrogen Action. Physiol Rev 2001; 81: 1535-65
23. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001; 81: 1269-304
24. Pettersson K, Gustafsson JA. Role of Estrogen Recepteur Beta in Estrogen Action. Annu Rev Physiol 2001; 63: 165-92
25. Routledge EJ, White R, Parker MG, et al. Differential effects of xenœstrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J Biol Chem 2000; 75: 35986-93
26. Revelli A, Massobrio M, Tesarik J. Nongenomic actions of steroid hormones in reproductive tissues. Endocr Rev 1998; 19: 3-17
27. Aronica SM, Kraus WL, Katzenellenbogen BS. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci U S A 1994; 91: 8517-21
28. Le MV, Grosse B, Lieberherr M. Phospholipase C beta and membrane action of calcitriol and estradiol. J Biol Chem 1997; 272: 11902-7
29. Tesarik J, Mendoza C. Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab 1995; 80: 1438-43
30. Nadal A, Diaz M, Valverde MA. The estrogen trinity: membre, cytosolic, and nuclear effects. News in phsiological Sciences 2001; 16: 251-5
31. Davis PJ, Tillmann HC, Davis FB, et al. Comparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones. J Endocrinol Invest 2002; 25: 377-88
32. Bjornstrom L, Sjoberg M. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol 2002; 16: 2202-14
33. Kousteni S, Bellido T, Plotkin LI, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001; 104: 719-30
34. Pappas TC, Gametchu B, Watson CS. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 1995; 9: 404-10
35. Razandi M, Pedram A, Greene GL, et al. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol 1999; 13: 307-19
36. Castoria G, Barone MV, Di Domenico M, et al. Non-transcriptional action of œstradiol and progestin triggers DNA synthesis. EMBO J 1999; 18: 2500-10
37. Migliaccio A, Castoria G, Di Domenico M, et al. Steroid-induced androgen receptor-œstradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 2000; 19: 5406-17
38. Migliaccio A, Di Domenico M, Castoria G, et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol- receptor complex in MCF-7 cells. EMBO J 1996; 15: 1292-300
39. Endoh H, Sasaki H, Maruyama K, et al. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Re. Commun 1997; 235: 99-102
40. Kousteni S, Bellido T, Plotkin LI, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001; 104: 719-30
41. Hisamoto K, Ohmichi M, Kurachi H, et al. Estrogen induces the Akt-dependent activation of endothelial nitric- oxide synthase in vascular endothelial cells. J Biol Chem 2001; 276: 3459-67
42. Simoncini T, Hafezi-Moghadam A, Brazil DP, et al. Interaction of œstrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000; 407: 538-41
43. Gu Q, Korach KS, Moss RL. Rapid action of 17beta-estradiol on kainate-induced currents in hippocampal neurons lacking intracellular estrogen receptors. Endocrinology 1999; 140: 660-6
44. Gronemeyer H. Control of transcription activation by steroid hormone receptors. Faseb J 1992;6:2524-9
45. Ellis DV, Pattisina LA. Widerspread neogastropod imposex: a biological indicator of TBT contamination. Mar Pollut Bull 1990; 21: 248-53
46. Short JW, Rice SD, Brodersen CC, et al. Occurrence of tri-N-butyltin caused imposex in the north pacific marine snail Nucella limaz in Auke Bay, Alaska. Mar Biol 1989; 102: 291-7
47. Bryan GW, Gibbs PE, Hummerstone LG, et al. The decline of the gastropod Nucella lapillus around south-west England: evidence for the effect of tributyltin from antifouling paints. J Mar Biol Assoc UK 1986; 66: 611-40
48. Smith BS. Reproductive anomalies in stenoglossan snails caused by antifouling bottom paints. J Appl Toxicol 1981; 1: 15-21
49. Heidrich DD, Steckelbrœck S, Klingmuller D. Inhibition of human cytochrome P450 aromatase activity by butyltins. Steroids 2001; 66: 763-9
50. Gooding MP, Wilson VS, Folmar LC, et al. The biocide tributyltin reduces the accumulation of testosterone as fatty acid esters in the mud snail (Ilyanassa obsoleta). Environ Health Perspect 2003; 111: 426-30
51. Gibbs PE, Bryan GW. TBT induced imposex in neogastropod. In: S.J.d. Mora (ed.), Tributyltin: case study of an environmental contaminant 1996; 212-36
52. Guillette LJ, Jr, Gross TS, et al. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect 1995; 102: 680-8
53. Guillette LJ, Jr, Pickford DB, et al. Reduction in penis size and plasma testosterone concentrations in juvenile alligators living in a contaminated environnement. Gen Comp Endocrinol 1996; 101: 32-42
54. Crain DA, Guillette LJ, Rooney A, et al. Alterations in steroidogenesis in alligators (alligator mississippiensis) exposed naturally and experimentally to environmental contaminants. Environ Health Perspect 1997; 105: 528-33
55. Guillette LJ, Brock JW, Rooney AA, et al. Serum concentration of various environmental contaminants and their relationship to sex steroid concentration and phallus size in juvenile American alligators. Arch Environ Contam Toxicol 1999; 36: 447-55
56. Bishop CA, Brooks RJ, Carey JH, et al. The case for a cause-effect linkage between environmental contamination and development in egg of the common snapping turtle (chelydra serpentina) from Ontario, Canada. J Toxicol Environ Health 1991; 33: 521-47
57. Bishop CA, Norstrom PN, RJ, et al. Temporal and geographic variation of organochlorine residues in eggs of the common snapping turtle (chelydra serpentina serpentina) (1981-1991) and comparaison to trends in the herring gull (Larus argentatus) in the Great Lakes basin in Ontario, Canada. Arch Environ Contam Toxicol 1996; 31: 512-24
58. Bishop CA, Lean DRS, Brooks RJ, et al. Chlorinated hydrocarbons in early life stages of the common snappling turtle (chelydra serpentina serpentina) from a coastal wetland on lake Ontario, Canada. Environ Toxicol Chem 1995; 14: 421-6
59. Crisp TM, Clegg ED, Cooper RL, et al. Environmental endocrine disruption: An effects assessment and analysis [Review]. Environ. Health Perspect 1998; 106: 11-56
60. Tyler CR, Jobling S, Sumpter JP. Endocrine disruption in wildlife: A critical review of the evidence. Crit Rev Toxicol 1998; 28: 319-61
61. Vos JG, Dybing E, Greim HA, et al. Health effects of endocrine-disrupting chemicals on wildlife, with special reference to the European sitation. Crit Rev Toxicol 2000; 30: 71-133
62. Peakall DB, Fox GA. Toxicological investigations of pollutant-related effects in Great Lakes gulls. Environ Health Perspect 1987; 71: 187-93
63. Gilbertson M, Kubiak T, Ludwig J, et al. Great Lakes embryo mortality, edema, and deformities syndrome (GLEMEDS) in colonial fish-eating birds: similarity to chick-edema disease. J Toxicol Environ Health 1991; 33: 455-520
64. Jones PD, Giesy JP, Newsted JL, et al. Accumulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalents by double-crested cormorant (Phalacrocorax auritus, Pelicaniformes) chicks in the North American Great Lakes. Ecotoxicol Environ Saf 1994; 27: 192-209
65. Fry DM, Toone CK. DDT-induced feminization of gull embryos. Science 1981; 213: 922-4
66. Fry DM, Toone CK, et al. Sex ratio skew and breeding patterns of gulls: demographic and toxicological considerations. Stud Avian Biol 1987; 10: 26-43
67. Hunt GLJ, Hunt MW. Female-female pairing in western gulls (Larus occidentalis) in southern California. Science 1977; 196: 1466-7
68. Purdom CE, Hardiman PA, Bye VJ, et al. Estrogenic effects of effluents from sewage treatment works. Chem Ecol 1994; 8: 275-85
69. Munkittrick KR, Port CB, Van Der Kraak GJ, et al. Impact of bleach kraft mill effluent on population characteristics, liver MFO activity, and serum steroid levels of a Lake Superior white sucker (Catostomus commersoni). Can J Fish Aquat Sci 1991; 45: 1371-80
70. Facemire CF, Gross TS, Guillette LJ, et al. Reproductive impairment in the Florida panther: nature or nuture? Environ Health Perspect 1995; 103: 79-86
71. Reijnders PJ. Reproductive failure in common seals feeding on fish from polluted coastal waters. Nature 1986; 324: 456-7
72. Jensen S, Jansson B, Olsson M. Number and identity of anthropogenic substances known to be present in Baltic seals and their possible effects on reproduction. Ann N Y Acad Sci 1979; 320: 436-48
73. Norstrom RJ, Muir DC. Chlorinated hydrocarbon contaminants in arctic marine mammals. Sci Total Environ 1994; 154: 107-28
74. Oskam IC, Ropstad E, Dahl E, et al. Organochlorines affect the major androgenic hormone, testosterone, in male polar bears (Ursus maritimus) at Svalbard. J Toxicol Environ Health A 2003; 66: 2119-39
75. Kleivane L, Severinsen T, Skaare JU. Biological transport and mammal to mammal transfer of organochlorines in Arctic fauna. Mar Environ Res 2000; 49: 343-57
76. Massart F, Becherini L, Noci I, et al. Analysis of estrogen receptor (ERa and ERb) and progesterone receptor (PR) polymorphisms in uterine leiomyomas. Médecine/Sciences 2003; 9: 25-30
77. Davis D, et al. Medical hypothesis: xenœstrogens as preventable causes of breast cancer, Environmental Health Perspect 1993; 101: 372-7
78. Ayotte P, Dewailly E, Brisson J. L'exposition aux composés organochlorés estrogéniqes et le cancer du sein. BISE 1994; 5: 4 [letter]
79. Coumoul X, Barouki R. Génotoxicité des métabolites des œstrogènes et cancers. Médecine-Sciences 2002; 18: 86-90
80. Matlai P, Beral V. Trends in congenital malformations of external genitalia. Lancet 1985; 1: 108 [letter]
81. Davis DL, Bradlow L. Estrogènes et cancer du sein. Pour la Science 1995; 218: 74-80
82. Wolff MS, Toniolo PG, Lee EW, et al. Blood levels of organochlorine residues and risk of breast cancer. J. Natl. Cancer Inst 1993; 85: 648-52
83. Yves L. Les micropolluants à effets modulateurs endocriniens. Spectra Analyses 1999; 208: 19-22
84. Shapiro S, Slone D. The effects of exogenous female hormones on the fetus. Epidemiol Rev 1979; 1: 110-23
85. Giusti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 1995; 122: 778-88
86. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971; 284: 878-81
87. Whitehead ED, Leiter E. Genital abnormalities and abnormal semen analyses in male patients exposed to diethylstilbestrol in utero. J Urol 1981; 125: 47-50
88. Toppari J, Larsen JC,Christiansen P, et al. Male reproductive health and environmental xenœstrogens. Environmental Health Perspectives 1996; 104: 741-803
89. Swan SH, Elkin EP, Fenster L. Have sperm densities declined? A reanalysis of global trend data. Environ Health Perspect 1997; 105: 1228-32
90. Carlsen E, Giwercman A, Keiding N et al. Evidence for decreasing quality of semen during past 50 years. BMJ 1992; 305: 609-13
91. Swan SH, Elkin EP, Fenster L. The question of declining sperm density revisited: an analysis of 101 studies published 1934-1996. Environ Health Perspect 2000; 108: 961-6
92. Sharpe RM, Skakkebaek NE. Are œstrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993; 341: 1392-5
93. Rasmussen PE, Erb K, Westergaard LG, et al. No evidence for decreasing semen quality in four birth cohorts of 1,055 Danish men born between 1950 and 1970. Fertil Steril 1997; 68: 1059-64
94. Fisch H, Goluboff ET Geographic variations in sperm counts: a potential cause of bias in studies of semen quality. Fertil Steril 1996; 65: 1044-6
95. Fisch H, Goluboff ET, Olson JH, et al. Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality. Fertil Steril 1996; 65: 1009-14
96. Paulsen CA, Berman NG, Wang C. Data from men in greater Seattle area reveals no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fertil Steril 1996; 65: 1015-20
97. Auger J, Kunstmann JM, Czyglik F, et al. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 1995; 332: 281-5
98. Ivrine S, Cawood E, Richardson D, et al. Evidence of deterioratig semen quality in the United Kingdom: brith cohort study in 577 men in Scotland over 11 years. BMJ 1996; 312: 467-71
99. Van Waeleghem K, De Clercq N, Vermeulen L, et al. Deterioration of sperm counts of Finnish men. Int. J. Androl 1996; 19: 11-7
100. Chen YCJ, et al. Cognitive Development of YuCheng ("Oil Disease") Children Prenatally Exposed to HeatDegraded PCBs. JAMA 1992; 268: 3213-18
101. Jacobson JL, et al. Effects of Prenatal PCB Exposure on Cognitive Processing Efficiency and Sustained Attention. Developmental Psychology 1992; 28: 297-306
102. Andersen HR, Andersen AM, Arnold SF, et al. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ. Health Perspect 1999; 107: 89-108
103. Krey G, Braissant O, L'Horset F, et al. Fatty acids, eicosanoids and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997; 11: 779-91
104. Nishkawa J, Saito K, Goto J, et al., New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicol Appl Pharmacol 1999; 154: 76-83
105. Soto AM, Fernandez MF, Luizzi MF, et al. Developing a marker of exposure to xenœstrogen mixtures in human serum. Environ. Health Perspect 1997; 105: 647-54
106. Ren LF, Marquardt MA, Lech JJ. Estrogenic effects of nonylphenol on PS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7. Chem. Interact 1997; 104: 55-64
107. McLachlan JA. Functional toxicology: a new approach to detect biologically active xenobiotics. Environ Health Perspect 1993; 101: 386-7
108. Metzger D, Ali S, Bornert JM, et al. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem 1995; 270: 9535-42
109. Ramamoorthy K, Wang F, Chen IC, et al. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism. Endocrinology 1997; 138: 1520-7
110. Petit F, Valotaire Y, Pakdel F. Differential functional activities of rainbow trout and human estrogen receptors expressed in the yeast Saccharomyces cerevisiae. Eur J Biochem 1995; 233: 584-92
111. Zysk JR, Johnson B, Ozenberger BA, et al. Selective uptake of estrogenic compounds by Saccharomyces cerevisiae: a mechanism for antiestrogen resistance in yeast expressing the mammalian estrogen receptor. Endocrinology 1995; 136: 1323-6
112. Arnold SF, Robinson MK, Notides AC, et al. A yeast estrogen screen for examining the relative exposure of cells to natural and xenœstrogens. Environ Health Perspect 1996; 104: 544-8
113. Arnold SF, Klotz DM, Collins BM, et al. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 1996; 272: 1489-92
114. Legler J, Dennekamp M, Vethaak AD, et al. Detection of estrogenic activity in sediment-associated compounds using in vitro reporter gene assays. Sci Total Environ 2002; 293: 69-83
115. Beresford N, Routledge EJ, Harris CA, et al. Issues arising when interpreting results from an in vitro assay for estrogenic activity. Toxicol Appl Pharmacol 2000; 162: 22-33
116. Graumann K, Jungbauer A. Agonistic and synergistic activity of tamoxifen in a yeast model system. Biochem Pharmacol 2000; 59: 177-85
117. Balaguer P, François F, Comunale F, et al. Reporter cell lines to study the estrogenic effects of xenœtrgens. Sci. Total Environ 1999; 233: 47-56
118. Balaguer P, Fenet H, Georget V, et al. Reporter Cell Lines to Monitor Steroid and Antisteroid Potential of Environmental Samples. Ecotoxicology 2000; 9: 105-14
119. Balaguer P, Boussioux AM, Demirpence E, et al. Reporter cell lines are useful tools for monitoning biological activity of nuclear receptor ligands. Luminescence 2001; 16: 153-8
120. Terouanne B, Tahiri B, Georget V, et al. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. Mol. Cell. Endocrinol 2000; 160: 39-49
121. Balaguer P, Lacoste C, Pilon A, et al. Détection d'activité œstrogénique dans les milieux biologiques à l'aide d'une lignée cellulaire bioluminescente. Gynecol Obstet 2001; 8: 354-7
122. Alam J, Cook JL. Reporter genes: application to the study of mammalian gene transcription. Anal Biochem 1990; 188: 245-54
123. Jain VK, Magrath IT. A chemiluminescent assay for quantitation of beta-galactosidase in the femtogram range: application to quantitation of beta-galactosidase in lacZ-transfected cells. Anal Biochem 1991; 199: 119-24
124. Turcotte B, Meyer ME, Bellard M, et al. Control of transcription of the chicken progesterone receptor gene. in vitro and in vivo studies. J Biol Chem 1991; 266: 2582-9
125. Zacharewski TR, Bondy KL, McDonell P, et al. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression. Cancer Res 1994; 54: 2707-13
126. Cavaillès V, Augereau P, Rochefort H. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci U S A 1993; 90: 203-7
127. Pons M, Gagne D, Nicolas JC, et al. A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. Biotechniques 1990; 9: 450-9
128. Demirpence E, Duchesne MJ, Badia E, et al. MVLN cells: a bioluminescent MCE-7-derived cell line to study the modulation of estrogenic activity. J Steroid Biochem Mol Biol 1993; 46: 355-64
129. Cavaillès V, Garcia M, Rochefort H. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol 1989; 3: 552-8
130. Nunez AM, Berry M, Imler JL, et al. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to œstrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J 1989; 8: 823-9
131. Murk AJ, Legier J, Denison MS, et al. Chemical-activated luciferase gene expression (CALUX): a novel in vitro bioassay for Ah receptor active compounds in sediments and pore water. Fundam Appl Toxicol 1996; 33: 149-60
132. Legier J, van den Brink CE, Brouwer A, et al. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 1999; 48: 55-66
133. Letcher RJ, Lemmen JG, van der Burg B, et al. in vitro antiestrogenic effects of aryl methyl sulfone metabolites of polychlorinated biphenyls and 2,2-bis(4-chlorophenyl)-1,1-dichlorœthene on 17beta-estradiol-induced gene expression in several bioassay systems. Toxicol Sci 2002; 69: 362-72
134. Hamers T, van den Brink PJ, Mos L, et al. Estrogenic and esterase-inhibiting potency in rainwater in relation to pesticide concentrations, sampling season and location. Environ Pollut 2003; 123: 47-65
135. Murk AJ, Legler J, van Lipzig MM, et al. Detection of estrogenic potency in wastewater and surface water with three in vitro bioassays. Environ Toxicol Chem 2002; 21: 16-23
136. Jain S, Dolwick KM, Schmidt JV, et al. Potent transactivation domains of the Ah receptor and the Ah receptor nuclear translocator map to their carboxyl termini. J Biol Chem 1994; 269: 31518-24
137. Lemaire G, Mnif W, Pascussi JM, et al. Identification of new human PXR ligands among pesticides using a stable reporter cell system. Toxicological Science 2006; 91: 501-9
138. Mnif W, Pascussi JM, Pillon A, et al. Estrogens and antiestrogens activate hPXR. Toxicology Letters 2007; 170: 19-29
139. Gutendorf B, Westendorf J. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytœstrogens and xenœstrogens. Toxicology 2001; 166: 79-89
140. Whitten PL, Patisaul HB. Cross-species and interassay comparisons of phytœstrogen action. Environ. Helth Perspect 2001; 109: 5-20